Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis is a chronic inflammatory disease that affects the central nervous system and can cause various types of pain including ongoing extremity pain, Lhermitte's phenomenon, trigeminal neuralgia, and mixed pain. Neuropathic pain is a major concern for individuals with multiple sclerosis as it is directly linked to myelin damage in the central nervous system and the management of neuropathic pain in multiple sclerosis is challenging as the options available have limited efficacy and can cause unpleasant side effects. The literature search was conducted across two databases, PubMed, and Google Scholar. Eligible studies included clinical trials, observational studies, meta-analyses, systematic reviews, and narrative reviews. The objective of this article is to provide an overview of literature on pharmacological and non-pharmacological strategies employed in the management of neuropathic pain in multiple sclerosis. Pharmacological options include cannabinoids, muscle relaxants (tizanidine, baclofen, dantrolene), anticonvulsants (benzodiazepines, gabapentin, phenytoin, carbamazepine, lamotrigine), antidepressants (duloxetine, venlafaxine, tricyclic antidepressants), opioids (naltrexone), and botulinum toxin variants, which have evidence from various clinical trials. Non-pharmacological approaches for trigeminal neuralgia may include neurosurgical methods. Non-invasive methods, physical therapy, and psychotherapy (cognitive behavioral therapy, acceptance and commitmen…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Meditation has also been shown to modulate the inflammatory response and reduce pain, possibly through neuroendocrine and immune system interactions [93].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [93]
In the citing paper
“Meditation has also been shown to modulate the inflammatory response and reduce pain, possibly through neuroendocrine and immune system interactions [93].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [93]
In the citing paper
“These findings are consistent with broader evidence supporting exercise-based therapies in autoimmune-related chronic pain conditions [93].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [93]
Citations
Cites
2 retracted
Wang, H.-Y., Frankfurt, M., & Burns, L. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001554 · Cited by 81
RetractedBoiko, D. I., Skrypnikov, A. M., Shkodina, A. D., Hasan, M. M., Ashraf, G. M., & Rahman, M. H. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-18384-4 · Cited by 76
Self-citationRetractedPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980 · cited 2×
“A meta-analysis of double-blind studies found that topical or oral pharmacological therapy can effectively treat NP [90].”
Central sensitization: a generator of pain hypersensitivity by central neural plasticity
Latremoliere, A., & Woolf, C. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.012 · Cited by 3,913
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15767 · Cited by 3,163
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520970841 · Cited by 2,653
Lefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Research works printed but not linked: 4
- Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group. Neurology. 1994;44:S34–42 (discussion S42–3).
- Belousov AN, Belousova EY, Lekomtseva YV. Prospects for the application of nanotechnology in the treatment of multiple sclerosis. Int J Clin Med Case Rep. 2023;2:1–8. https://doi.org/10.31579/2834-8664/017. · doi:10.31579/2834-8664/017
- Boiko DI, Kachur RV, Ajala OM, Bodnar LA, Zhyvotovska LV. Characteristics of anxiety and depressive manifestations in patients with acute myocardial infarction taking into account their personal accentuations. Azerbaijan Med J. 2021;2:25–31. https://doi.org/10.34921/amj.2021.2.004. · doi:10.34921/amj.2021.2.004
- Hasanpour DA. Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: a randomized trial. J Sports Med Phys Fitness. 2016;56:1417–22.
Cited by
Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation
Nunez, S. G., Rabelo, S. P., Subotic, N., Caruso, J. W., & Knezevic, N. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209994 · Cited by 138
“These findings are consistent with broader evidence supporting exercise-based therapies in autoimmune-related chronic pain conditions [93].”
Shaheen, K., Alam, A., Elhenawy, A. A., Khan, I. A., Rahman, F. U., Ali, A., Rehman, M. U., AlAsmari, A. F., Alasmari, F., Ahmad, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-13351-2 · Cited by 10
“Besides, compound 7 demonstrated some activity, with a 26.66% reduction in edema, while compounds 6 , 8 , and 4 showed minimal activity, with reductions of 13.33%, 10.00% and 3.33%, respectively.”
InfluentialNeuropathic pain in multiple sclerosis: serum biomarkers and MRI lesion localization
Ismail, M. H., ELmotayam, A. S., Saadawy, S. F., Elfwakhry, R. M., Fawzy, H. M., & Sarhan, N. T. (2025) · The Egyptian Journal of Neurology, Psychiatry and Neurosurgery · doi:10.1186/s41983-025-00955-8 · Cited by 2
“Consequently, there is a demand for newer alternatives that are based on established pathophysiological mechanisms, which offer enhanced effectiveness and/or decreased side effects [29].”
Jungersen, R. C., Baccaro, V. K., Hvid, L. G., Dalgas, U., & Hoegh, M. (2026) · European Journal of Pain · doi:10.1002/ejp.70375 · Cited by 1
Metadata
- Authors
- Shkodina, A. D., Bardhan, M., Chopra, H., Anyagwa, O. E., Pinchuk, V. A., Hryn, K. V., Kryvchun, A. M., Boiko, D. I., Suresh, V., Verma, A., & Delva, M. Y.
- Affiliations
- Poltava State Medical University (UA)
- Baptist Hospital of Miami (US)
- Saveetha University (IN)
- New Vision University (GE)
- King George's Medical University (IN)
- Corresponding author
- Bardhan, Mainak
- ORCID
- Venue
- CNS Drugs
- Published
- 2024-02-29
- Volume
- 38
- Issue
- 3
- Pages
- 205-224
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W4392293990
- Cited by
- 31
- References
- 188
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 6
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Poltava State Medical University (0120U104165, 0121U108235)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- multiple sclerosis, neuropathic pain, trigeminal neuralgia, mixed pain, cannabinoids, muscle relaxants, antiepileptic drugs, antidepressants, opioids, botulinum toxin, non-pharmacological treatment, cognitive behavioral therapy, acceptance and commitment therapy, mindfulness-based stress reduction, physiotherapy, neurosurgery
- MeSH terms
- Anticonvulsants, Antidepressive Agents, Humans, Multiple Sclerosis, Neuralgia, Trigeminal Neuralgia, Acceptance and Commitment Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis. https://app.cochat.ai/papers/10.1007/s40263-024-01072-5
- The paper
- Shkodina, A. D., Bardhan, M., Chopra, H., Anyagwa, O. E., Pinchuk, V. A., Hryn, K. V., Kryvchun, A. M., Boiko, D. I., Suresh, V., Verma, A., & Delva, M. Y. (2024). Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis. CNS Drugs. https://doi.org/10.1007/s40263-024-01072-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.